TSHA Annual FCF
-$80.39 M
+$32.87 M+29.02%
31 December 2023
Summary:
As of January 23, 2025, TSHA annual free cash flow is -$80.39 million, with the most recent change of +$32.87 million (+29.02%) on December 31, 2023. During the last 3 years, it has fallen by -$40.58 million (-101.92%). TSHA annual FCF is now -101.92% below its all-time high of -$39.81 million, reached on December 31, 2020.TSHA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA Quarterly FCF
-$21.65 M
+$55.00 K+0.25%
30 September 2024
Summary:
As of January 23, 2025, TSHA quarterly free cash flow is -$21.65 million, with the most recent change of +$55.00 thousand (+0.25%) on September 30, 2024. Over the past year, it has dropped by -$201.00 thousand (-0.94%). TSHA quarterly FCF is now -274.55% below its all-time high of $12.40 million, reached on December 31, 2022.TSHA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA TTM FCF
-$79.43 M
-$201.00 K-0.25%
30 September 2024
Summary:
As of January 23, 2025, TSHA TTM free cash flow is -$79.43 million, with the most recent change of -$201.00 thousand (-0.25%) on September 30, 2024. Over the past year, it has dropped by -$27.58 million (-53.19%). TSHA TTM FCF is now -4574.93% below its all-time high of -$1.70 million, reached on March 31, 2020.TSHA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +29.0% | -0.9% | -53.2% |
| 3 y3 years | -101.9% | +39.8% | +31.4% |
| 5 y5 years | - | - | - |
TSHA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.0% | -274.6% | +58.7% | -53.2% | +55.5% |
| 5 y | 5-year | -101.9% | +42.0% | -274.6% | +58.7% | -4574.9% | +55.5% |
| alltime | all time | -101.9% | +42.0% | -274.6% | +58.7% | -4574.9% | +55.5% |
Taysha Gene Therapies Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$21.65 M(-0.3%) | -$79.43 M(+0.3%) |
| June 2024 | - | -$21.70 M(+8.9%) | -$79.23 M(+3.9%) |
| Mar 2024 | - | -$19.94 M(+23.6%) | -$76.24 M(-5.2%) |
| Dec 2023 | -$80.39 M(-29.0%) | -$16.13 M(-24.8%) | -$80.39 M(+55.0%) |
| Sept 2023 | - | -$21.45 M(+14.6%) | -$51.85 M(-16.7%) |
| June 2023 | - | -$18.72 M(-22.3%) | -$62.23 M(-26.8%) |
| Mar 2023 | - | -$24.09 M(-294.2%) | -$84.98 M(-25.0%) |
| Dec 2022 | -$113.26 M | $12.40 M(-139.0%) | -$113.26 M(-35.1%) |
| Sept 2022 | - | -$31.83 M(-23.2%) | -$174.44 M(-2.3%) |
| June 2022 | - | -$41.47 M(-20.8%) | -$178.54 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$52.37 M(+7.4%) | -$168.39 M(+21.5%) |
| Dec 2021 | -$138.60 M(+248.1%) | -$48.78 M(+35.7%) | -$138.60 M(+19.8%) |
| Sept 2021 | - | -$35.94 M(+14.8%) | -$115.72 M(+33.7%) |
| June 2021 | - | -$31.31 M(+38.7%) | -$86.53 M(+42.6%) |
| Mar 2021 | - | -$22.57 M(-12.9%) | -$60.68 M(+52.4%) |
| Dec 2020 | -$39.81 M | - | - |
| Dec 2020 | - | -$25.90 M(+283.9%) | -$39.81 M(+186.2%) |
| Sept 2020 | - | -$6.75 M(+23.4%) | -$13.91 M(+94.2%) |
| June 2020 | - | -$5.47 M(+221.7%) | -$7.17 M(+321.7%) |
| Mar 2020 | - | -$1.70 M | -$1.70 M |
FAQ
- What is Taysha Gene Therapies annual free cash flow?
- What is the all time high annual FCF for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual FCF year-on-year change?
- What is Taysha Gene Therapies quarterly free cash flow?
- What is the all time high quarterly FCF for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly FCF year-on-year change?
- What is Taysha Gene Therapies TTM free cash flow?
- What is the all time high TTM FCF for Taysha Gene Therapies?
- What is Taysha Gene Therapies TTM FCF year-on-year change?
What is Taysha Gene Therapies annual free cash flow?
The current annual FCF of TSHA is -$80.39 M
What is the all time high annual FCF for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual free cash flow is -$39.81 M
What is Taysha Gene Therapies annual FCF year-on-year change?
Over the past year, TSHA annual free cash flow has changed by +$32.87 M (+29.02%)
What is Taysha Gene Therapies quarterly free cash flow?
The current quarterly FCF of TSHA is -$21.65 M
What is the all time high quarterly FCF for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly free cash flow is $12.40 M
What is Taysha Gene Therapies quarterly FCF year-on-year change?
Over the past year, TSHA quarterly free cash flow has changed by -$201.00 K (-0.94%)
What is Taysha Gene Therapies TTM free cash flow?
The current TTM FCF of TSHA is -$79.43 M
What is the all time high TTM FCF for Taysha Gene Therapies?
Taysha Gene Therapies all-time high TTM free cash flow is -$1.70 M
What is Taysha Gene Therapies TTM FCF year-on-year change?
Over the past year, TSHA TTM free cash flow has changed by -$27.58 M (-53.19%)